Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Beyar-Katz, Ofrat; Dickstein, Yaakov; Borok, Sara; Vidal, Liat; Leibovici, Leonard; Paul, Mical.
Cochrane Database Syst Rev
; 6: CD003914, 2017 06 03.
Artigo em Inglês | MEDLINE | ID: mdl-28577308
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature.
Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study.
Oritavancin: A Novel Lipoglycopeptide.
Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.